| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.15 | 0.6 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.13 | 0.6 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |